Where VLS Pharmacy fits in the 503A stack
Compounded medication for cash-pay clinics flows through a fixed chain: the prescriber writes a patient-specific Rx, submits it directly to a 503A compounding pharmacy, which compounds and ships. VLS Pharmacy is that 503A pharmacy for its network — it occupies the compounder role, not the ordering-platform role. Its two locations (VLS in Brooklyn for sterile compounding and New Drug Loft in Manhattan for non-sterile) fill the prescriptions your clinic submits by fax, EMR, or phone, compounding each one to patient specifications.
Fizy Health sits in a different layer. It is not a compounder — it is the ordering and checkout layer above a network of LegitScript-certified 503A partners. It resolves per-vial cost on each catalog and cart line before checkout, validates SIGs, prescriber state licensure, and stock before payment, and batches the whole day's patient list into one cart. The trade-off is whether the clinic wants a direct relationship with VLS's sterile compounding expertise or a batch-checkout workflow with pass-through pricing across multiple 503A partners.